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Abstract
Eukaryotic DNA polymerase d (pol d) plays a crucial role in chromosomal DNA replication and various DNA repair processes.
It is thought to consist of p125, p66 (p68), p50 and p12 subunits. However, rigorous isolation of mammalian pol d from
natural sources has usually yielded two-subunit preparations containing only p125 and p50 polypeptides. While
recombinant pol d isolated from infected insect cells have some problems of consistency in the quality of the preparations,
and the yields are much lower. To address these deficiencies, we have constructed recombinant BmNPV baculoviruses using
MultiBac system. This method makes the generation of recombinant forms of pol d containing mutations in any one of the
subunits or combinations thereof extremely facile. From about 350 infected larvae, we obtained as much as 4 mg of pol d
four-subunit complex. Highly purified enzyme behaved like the one of native form by rigorous characterization and
comparison of its activities on poly(dA)/oligo(dT) template-primer and singly primed M13 DNA, and its homogeneity on
FPLC gel filtration. In vitro base excision repair (BER) assays showed that pol d plays a significant role in uracil-intiated BER
and is more likely to mediate LP BER, while the trimer lacking p12 is more likely to mediate SN BER. It seems likely that loss
of p12 modulates the rate of SN BER and LP BER during the repair process. Thus, this work provides a simple, fast, reliable
and economic way for the large-scale production of human DNA polymerase d with a high activity and purity, setting up a
new platform for our further research on the biochemical properties of pol d, its regulation and the integration of its
functions, and how alterations in pol d function could contribute to the etiology of human cancer or other diseases that can
result from loss of genomic stability.
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Introduction
The complete and accurate replication of the genome is a central
process in biology [1,2]. In higher organisms this involves multiple
processes as well as complex regulatory mechanisms that allow the
temporally coordinated duplication of the chromosomes during the
cell cycle. DNA replication is performed by a complex assembly of
proteins, the replisome, at the heart of which are the DNA
polymerases that drive the central process of DNA synthesis at the
replication fork [3]. Among three major replicative polymerases,
polymerase a (pol a), d (pol d), and e (pol e) in chromosomal DNA
synthesis, pol d plays a crucial role in DNA replication, and is
adapted for the lagging strand synthesis [4,5], but in addition also is
a major participant in DNA repair processes [3,6,7].
Mammalian pol d, discovered as a new eukaryotic DNA
polymerase, consists of the p125 catalytic subunit which harbors
both 59-39 DNA polymerase and 39-59-exonuclease activities and a
tightly associated second subunit p50 [8]. This core is associated
withtwo other subunits, p68 and p12, that arealsoreferred to as the
third and fourth subunit [9–11]. Thus, mammalian pol d contains
four subunits as a counterpart of fission yeast S. pombe pol d which
consists of four subunits, Pol3, Cdc1, Cdc27 and Cdm1 [12–14].
While in budding yeast, S. cerevisiae pol d is a trimer of the first three
subunits, Pol3p, Pol31p/Hys2, and Pol32p, encoded by two
essential genes, POL3 and POL31, and a non-essential gene
POL32, respectively [15,16]. It is surprising there have been
comparatively few studies of this important enzyme in human/
mammalian system, and our understanding of its fundamental
biochemical properties lags behind those of replicative polymerases
in other systems. Much of our progress has come from the studies in
yeast system. One of the major obstacles is the availability of highly
purified active pol d either as a native form isolated from
mammalian tissues or cultured cells and as a reconstitution form
produced from other expression system. Performed in an early
stage, the isolation of native pol d from mammalian tissues was
extremely tedious and only small amounts of enzyme protein could
be isolated [17,18]. Until 2002, a method was developed for the
production of recombinant human pol d and its subassemblies using
baculovirus expression system in infected insect cells with his-tagged
pol d subunits or unmodified, i.e., non-tagged subunits [19,20]. This
method involved co-infection with four separate baculoviruses
which allowed for the reconstitution of the recombinant human pol
d enzyme.However,thereweresome problemsofconsistencyinthe
quality of the preparations and the yields were still much lower than
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recombinant baculoviruses, there were variable amounts of suba-
ssemblies of pol d present in the infected insect cell lysates, which
meant additional purification and quality control experiments.
We have made a strong attempt to address this deficiency, and
in this work, we present: a). construction of human pol d by
inserting the cDNAs for its four subunits into a single recombinant
virus, each under the control of polyhedrin promoter in an
individual expression cassette, using the baculovirus MultiBac
system as described in [21]. This method makes the generation of
recombinant forms of pol d containing mutations in any one of the
subunits or combinations thereof extremely easy. b). expression
and its assembly of recombinant pol d heterotetramer in Bombyx
mori nucleopolyhedrovirus (BmNPV)–infected silkworm larvae
using Bombyx mori as a bioreactor [22]. c). protein purification to
near-homogeneity with a highly standardized protocol by home-
made immunoaffinity column and FPLC chromatography on
Mono Q column within 48 hours. As much as 4 mg of enzyme
from about 350 infected larvae was obtained. d). characterization
of purified enzyme by comparison of its specific activities, DNA
elongation ability, and its homogeneity with the native form
isolated from Hela cells on poly(dA)/oligo(dT) template-primer,
singly primed M13 DNA, and FPLC chromatography on gel
filtration column. Highly purified recombinant pol d from
BmNPV–infected silkworm larvae was shown to be functional
similar to the native pol d isolated from Hela cells. e). analysis of
the role of pol d involved in uracil-intiated BER in vitro. It seems
likely that loss of p12 modulates the rate of SN (single-nucleotide)
BER and LP (long patch) BER during the repair process.
Our researches provide a simple, fast, reliable and economic
way for the large-scale production of human DNA polymerase d
with a high specific activity and high purity. Thus, this work sets
up a new platform for our current research on the biochemical
properties of pol d, its regulation and the integration of its
functions, and how alterations in pol d function could contribute to
the etiology of human cancer or other diseases that can result from
loss of genomic stability.
Materials and Methods
Reagents and chemicals
All reagents and chemicals used in this study were purchased
from Sigma-Aldrich, Gibco-BRL, and Invitrogen except as
otherwise indicated. Mouse polyclonal antibody against p50
(ZJM5002), rabbit polyclonal antibodies against p125 (ZJR12501),
p68(ZJR6803) and p12(ZJR1204)werepreparedinourlaboratory,
respectively.
Construction of recombinant baculoviruses containing
multigene expression cassettes
Four cDNA fragments coding the full-length sequence of pol d
individual subunit were excised between the BamHI and XbaI sites
from the vector pCDNA3.1(+)-FLAG [23] containing the BamHI/
EcoRI insertion of p125, p50, p68, or p12, respectively [24]. To
construct the recombinant transfer vector pFBDM-[p125-p50-
p68-p12] for multigene expression, the logic of adding subunits
into polycistronic vector pFBDM is illustrated in Figure 1 with
MultiBac system, according to manufacturer’s instruction (kindly
provided by Dr. Timothy J. Richmond, Institute for Molecular
Biology and Biophysics, ETH Zu ¨rich, Switzerland) [21].
The obtained recombinant plasmid pFBDM-[p125-p50-p68-
p12] was then transformed into E. coli BmDH10Bac competent
cells which contain the BmNPV bacmid with a miniF replicon,
kanamycin-resistant gene, lacZ gene, mini-attachment Tn7 site,
and a helper plasmid [25,26]. Recombinant bacmid was obtained
through the transposition of the Tn7 elements from the pFBDM
derivative to the mini-attachment Tn7 target site on the BmNPV
bacmid. High molecular weight mini-prep DNA was prepared
from a selected white phenotype E. coli and used to transfect
silkworm BmN cells for the production of recombinant baculovirus
particles, according to manufacturer’s instruction (Invitrogen).
Expression and purification of recombinant human DNA
pol d
The variety of silkworm used in this work was ‘‘306’’ held by our
laboratory. About 350 larvae were used as the bioreactors for the
production of human polymerase delta. The second day of fifth
instar larvae were injected with 10 ml of viral solution
(3.1610
7 pfu/ml) per os. After 5 days post injection, infected
larvae were weighed, and the hemolymph was collected and
frozen at 280uC.
All purification steps were carried out at 4uC. The immunoaffi-
nity column, used for pol d complex purification, coupled with a
polyclonal antibody (ZJR12501) against human catalytic subunit
p125, was prepared using CarboLink
TM Immobilization Kit
according to manufacturer’s instruction (Pierce). Collected larval
hemolymph was centrifuged at 12,000 rpm for 30 min and
divided into two fractions. The supernatant fraction was diluted
three times with TGEE buffer (40 mM Tris-HCl, pH 7.8, 10%
glycerol, 0.5 mM EDTA, 0.1 mM EGTA) containing 0.1 M
NaCl, 1 mM phenylmethylsulfonate, and protease inhibitor
mixture, and then subjected to immunoaffinity chromatography
(20 ml agarose beads) and FPLC Mono Q 5/50 GL column (GE
Healthcare) as previously described [24]. Eluted fractions were
analyzed by 12.5% SDS-PAGE and Coomassie Blue staining.
In another protocol, the pellet fraction containing cell debris
and tissues was resuspended in lysis buffer (20 mM Tris-HCl,
pH 7.8, 10% glycerol, 0.5 mM EGTA, 1 mM EDTA, 1 mM
MgCl2, 200 mM NaCl, 0.1% NP-40, 1 mM phenylmethylsulfo-
nate, and protease inhibitor mixture) on ice for 30 min, disrupted
by sonicating using 4615 second bursts with a 15 second cooling
period between each burst, and centrifuged at 14,000 rpm for
60 min. Collected supernatant was diluted three times with TGEE
buffer and purified further on immunoaffinity column and FPLC
Mono Q column using the same protocol used for purification of
supernatant fraction of hemolymph.
FPLC gel filtration chromatography
A 250 ml sample from the peak fraction after FPLC Mono Q
ion exchange chromatography was loaded on a Superdex 200
column equilibrated with 150 mM NaCl in TGEED buffer
(TGEE plus 1 mM dithiothreitol). The column was eluted at a
flow rate of 0.25 ml/min, and a total of 90 fractions of 0.25 ml
each were collected.
Purification of the pol d complex from Hela cells
A protocol used for purification of pol d complex from Hela
cells was essentially as described for its isolation from HEK 293T
or Hela cells [27,28]. Total lysates from 80 plates (about 1.5610
8
cells) were loaded onto a 10-ml immunoaffinity column. Eluted
fractions across the peak were separated by 12.5% SDS-PAGE
and stained with Coomassie Blue or transferred to nitrocellulose
membrane for western blot analysis.
Purification of PCNA
Recombinant PCNA was expressed in E. coli and purified to
near homogeneity by a protocol as previously described [29], and
A Novel Strategy to Produce Human DNA Pol d
PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e22224A Novel Strategy to Produce Human DNA Pol d
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22224made some modifications. One liter of DH5-a cells harboring
human PCNA in pTACTAC vector were induced with 0.3 mM
IPTG for 18 hours at 27uC. The cells were harvested by
centrifugation at 4,000 rpm for 30 min, resuspended in 200 ml
of lysis buffer (25 mM Tris-HCl, 1 mM EDTA, 25 mM NaCl,
0.01% Nonidet P-40, 2 mM benzamidine, 2 mM pepstatin A,
1 mM PMSF, 1 mM DTT, 100 ug/ml lysozyme, pH 7.4), and
disrupted by sonicating. The lysates were centrifuged at
14,000 rpm for 60 min at 4uC. The supernatant was loaded onto
a Q-sepharose column (2.5638 cm) equilibrated with TGEED
buffer. The column was washed with 2 bed volumes of TGEED
containing 0.2 M KCl, followed by a linear gradient of KCl from
0.2 to 0.8 M (1,800 ml) at 2 ml/min. 8-ml fractions were collected
and PCNA was eluted between 0.4 and 0.5 M salt. Peak fractions
were pooled and dialyzed against TGEED. The dialyzed material
was then loaded onto a 4-ml Mono-P HR 5/20 column
equilibrated with TGEED. The column was washed with 2-bed
volumes of TGEED followed by 80 ml of a 0.2–0.8 M KCl
gradient at 1 ml/min. PCNA was eluted around 0.4–0.5 M KCl.
DNA polymerase assay
Assays for DNA polymerase activity were performed by
determination of [
3H]dTMP incorporated into poly(dA)/oligo(dT)
template/primer in the presence and absence of PCNA as
described previously [24,27]. One unit of DNA polymerase
activity corresponds to the incorporation of 1 nmole of dTMP
per hour at 37uC. Assays using singly primed M13 DNA as the
template were performed as previously described [24]. The
reactions were started by incubation at 37uC for 30 min and
stopped by addition of 20 mM EDTA. 5 ml aliquots of each
reaction were spotted onto DE81 papers which were washed 3
times with 0.3 M ammonium formate pH 7.8, once with 95%
ethanol, dried and counted using liquid scintillation counter. The
rest of the products were run on 1.5% alkaline agarose gel at 50 V
for 2.5 hours. The gel was dried and the product length was
visualized with a phosphoImager or evaluated on an x-ray film.
DNA ladder and oligonucleotide labeling
A 1 kb DNA ladder (New England Biolabs) for M13 assays and
25-mer oligonucleotide (59-GCCACTACAGCACCTTGACAG-
CCAG-39) [28] as a DNA maker for BER assays were end-labeled
with [c-
32P]ATP (5000 Ci/mmol, MP Biochemicals) in 16T4
kinase buffer containing T4 polynucleotide kinase (New England
Biolabs), followed by purification using the QIAquick nucleotide
removal kit (Qiagen).
Cellular extracts for In vitro BER assay
The wild-type mouse embryonic fibroblast (MEF) cell line and
the matched littermate pol b-knockout cell line [30] were the
generous gifts from Dr. Samuel H. Wilson. The conditions for cell
culture and preparation of cell extracts have been described
previously [31,32].
In vitro BER assay
A uracil-containing plasmid pUC19N, derived from pUC19
with additional 48-mer N.BstNB1 fragment, designed to discrim-
inate total BER, SN BER, and LP BER, was a generous gift
provided by Dr. Samuel H. Wilson and described as previously
[32,33]. Upon digestion with restriction enzyme KpnI, it would
generate a 41-bp fragment representing total BER product, while
digestion with XhoI and KpnI, it would generate a 25-bp fragment
representing SN BER plus LP BER and a 16-bp fragment
representing LP BER. For BER assays with cell extract, 10 mgo f
MEF extract prepared from wild-type or pol b 2/2 cells were
analyzed in a final volume of 10 ml containing 10 nM plasmid
DNA in 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 20 mM NaCl,
1 mM DTT, 4 mM ATP, 20 mM each dATP, dGTP, and dTTP,
and 2.3 mM[ a-
32P]dCTP. In experiments for depleting pol d, the
antibodies (ZJR12501, ZJM5002, ZJR6803, and ZJR1204)
specific for pol d four subunits were incubated with the cell
extract by rotation for 60 min at 4uC; protein A/G agarose beads
were then added; the mixture was incubated for another 30 min,
and the beads were removed by centrifugation at 2500 rpm for
5 min, before the repair reaction. The BER reaction mixture was
incubated at 37uC for 30 min. After phenol/chloroform extraction
and ethanol precipitation, the recovered reaction product was
subjected to the restriction-enzyme analysis. The digested products
were separated by electrophoresis on 16% denaturing polyacryl-
amide gel containing 8 M urea. Radioactive products were
visualized by phosphorimaging and analyzed with ImageQuant
software (Amersham Biosciences, NJ). For the calculation of SN
BER, arbitrary phosphorimager units in the 16-bp fragment were
subtracted from that of 25-bp fragment. For reconstitution BER
assay with purified recombinant proteins, the assays were
performed under similar reaction conditions as above except that
the cell extract was replaced by the following proteins as indi-
cated: I unit of E. Coli UDG (New England Biolabs), 2.5 units of
recombinant human APE-1(New England Biolabs), 1 unit of T4
ligase (Promega), 2 unit of recombinant human FEN-1 (Proteome
Resources, LLC), 100 ng of recombinant human PCNA, and
100 fmol of recombinant human pol d complexes.
Western blot analysis
Western blotting was performed as previously described [20].
Antibodies used in this experiment were ZJM5002, a mouse
polyclonal antibody against p50, ZJR12501, ZJR6803 and
ZJR1204 which are rabbit polyclonal antibodies against p125,
p68 and p12, respectively. After electrophoretic transfer, the
nitrocellulose membrane bounded by target proteins was stained
with Ponceau S and cut into four pieces according to the molecular
weight of each subunit. Four pieces of membrane were blocked with
5% w/v nonfat dry milk in TBST buffer (20 mM TrisHCl, pH 7.4,
150 mM NaCl, 0.05% Tween 20) for 1 hour at room temperature.
The blot was then incubated with individual primary antibody
corresponding to each subunit for 1 hour at room temperature or
overnight at 4uC. After three 15-min washes with TBST buffer, the
blot was incubated with AP-conjugated or HRP-conjugated goat
anti-mouse IgG or goat anti-rabbit IgG for 1 hour and washed with
TBST buffer 3 times for 10 min. Perfect Protein Western Blot Kit
(Novagen) was used for signal generation.
Protein determination
Protein was determined by the Bradford method with bovine
serum albumin as a standard, or by ‘‘in-gel’’ analysis of protein
Figure 1. A strategy for assembling multigene expression cassettes in pFBDM. Four genes, p125, p50, p68, and p12, were inserted into
MCS1 between BamHI and XbaI sites, respectively. The expression cassette containing p125 was excised by digestion with AvrII and PmeI (boxed) and
placed into a multiplication module (M) of a construct containing p50 via BstZ17I/SpeI sites. Followed the same logic, a pFBDM-[p125-p50-p68] was
generated by an insertion of the expression cassette containing p125 and p50 into a construct containing p68. Finally, a recombinant transfer vector
pFBDM-[p125-p50-p68-p12] was generated in which each subunit is under the control of individual polyhedrin promoter.
doi:10.1371/journal.pone.0022224.g001
A Novel Strategy to Produce Human DNA Pol d
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22224concentration of the catalytic subunit p125 using catalase as a
protein standard [28].
Results and Discussion
Construction of recombinant transfer vector containing
pol d four-subunit gene expression cassettes
The earlier study of the enzymology of the mammalian DNA
pol d had been extraordinarily difficult due to the small amounts of
enzyme protein available [10,17,18]. Rigorous purification of the
enzyme culminated in an isolation of two-subunit enzyme
containing a catalytic subunit of 125 kDa and a second subunit
of 50 kDa [17,34]. In previous studies [20,24], we had developed a
method to reconstitute the heterotetrameric form of pol d by co-
expression of four separate recombinant baculoviruses for its
individual subunit in Sf-9 insect cells. Since this method depended
on the co-infection of four different viruses, there existed variable
amounts of subassemblies of pol d in infected cell lysates, resulting
in the problems of consistency in the quality of the preparations.
In order to address this deficiency, in this work, a construction
of recombinant baculovirus containing multigene expression
cassettes was made using the MultiBac system as described [21].
Here, we chose to use the unmodified subunits, rather than any
tagged proteins that could result in the assembly of complexes
which might have modified or compromised properties. The
detailed logic of adding subunits is shown in Figure 1 in which a
recombinant transfer vector pFBDM-[p125-p50-p68-p12] con-
taining four gene expression cassettes was generated. Due to the
multiplication module between the two promoters, the pFBDM is
particularly suited for generating multigene expression cassettes,
making the generation of recombinant forms of pol d containing
mutations in any one of the subunits or different subunit
combinations thereof extremely easy.
Our previous studies indicated that the fourth subunit p12 was
not a passive structural element for the stability of pol d, but that
its interaction with the core dimer produced alterations in the
conformation and/or structure of the catalytic site that are
essential for the catalytic properties of the pol d holoenzyme
[24,28]. Pol d itself may be a target of the DNA damage response.
As genotoxic agents and replication stress triggered the degrada-
tion of the p12 subunit, pol d was converted to a trimeric form,
whose altered responses to encounters with DNA lesions might
contribute to the DNA damage response [28]. In order to provide
a foundation for assessing the contributions of p12 and p68 on the
functions of the catalytic core enzyme consisting of p125 and p50,
a rigorous analysis of the enzymatic behavior of pol d and its
subassemblies will be needed. Therefore, by the use of a similar
strategy, we also constructed the recombinant transfer vectors,
Figure 2. A schematic outline for generation of recombinant virus and its expression in silkworm larvae. The obtained recombinant
transfer vector pFBDM-[p125-p50-p68-p12] was introduced into BmNPV bacmid DNA in BmDH10Bac E. coli cells. Colonies containing bacmid carrying
integrated four-gene expression cassettes were identified by blue/white screening. Bacmid DNAs were isolated from selected white phenotypes. The
recombinant BmNPV viruses were generated by the transfection of BmN insect cells with isolated bacmid DNAs. The four subunit pol d complex was
then expressed and assembled in silkworm larvae by the infection of larvae with prepared recombinant viruses.
doi:10.1371/journal.pone.0022224.g002
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p50-p12] and pFBDM-[p125-p50-p68] lacking p68 or p12,
respectively.
Generation of recombinant BmNPV baculovirus
Since Maeda et al. first reported the production of human
a-interferon in silkworm using recombinant BmNPV [35],
silkworm larvae have been used as a bioreactor for the production
of huge recombinant proteins for decades. Recently a novel Bac-
to-Bac system using BmNPV is established by the construction of
BmNPV bacmid DNA with a miniF replicon (Escherichia coli
replication), kanamycin-resistant gene, lacZ gene, mini-attachment
Tn7 site [25], which possesses a comparable time saving, high
performance and high efficiency to Bac-to-Bac baculovirus
expression system using AcMNPV distributed from Invitrogen
Corp. In this work, we constructed a recombinant BmNPV
baculovirus for expression of pol d heterotetramer using this novel
system. A schematic outline for generation of recombinant virus is
shown in Figure 2. The obtained donor plasmid pFBDM-[p125-
p50-p68-p12] was transformed into E. coli BmDH10Bac compe-
tent cells. The white clones were selected and BmNPV bacmid
DNAs were isolated. Eight correct phenotypes verified by PCR
analysis were selected for the transfection of BmN cells. After 5
days post-transfection, the recombinant baculoviruses containing
four subunit gene expression cassettes were successfully obtained
based on the Western blotting analysis as shown in Figure 3. In
addition, we also prepared a set of recombinant viruses for pol d
subassemblies: dimer enzyme pol d-core, trimer pol d-p12 lacking
p12 subunit and trimer pol d-p68 lacking p68, respectively. The
transfections of BmN cells were identified by Western blotting
analysis as shown in Figure S1.
Expression and purification of the recombinant human
pol d four-subunit enzyme in silkworm larvae
The silkworm, Bombyx mori, has been used for silk production for
centuries. Recently, as an important well-identified model organism
in genetics, physiology, and biochemistry, it has been also expended
as a bioreactor for the production of recombinant proteins not only
for research applications but also for commercial purposes. In
general, the expression levels of recombinant proteins in silkworm
larvae are higher than those in cultured insect or mammalian cells.
The activities of human butyrylcholinesterase from the hemolymph
of infected silkworms were 23 or 280 times higher than those in
infected BmN or CHO cells [36]. From the hemolymph of ten
silkworm larvae, about 1 mg of human macrophage colony-
stimulating factor (M-CSF) could be isolated [37]. Even from
1 ml of collected hemolymph, 0.16 mg of human growth factor
could be obtained by purification [38]. While we have developed
efficient methods for the expression and purification of pol d and its
subassemblies, we have sought to improve both the quality and
yields to facilitate our work. Here we tested the expression and
assembling of human pol d four-subunit complex in silkworm larvae
for the first time. The silkworm ‘‘306’’, a BmNPV-sensitive variety,
was chosen as a bioreactor. After infection of the fifth instar larvae
by the injection with recombinant baculovirus for four-subunit
expression, about 50 ml of hemolymph from 350 infected larvae
was collected and the expression levels were judged by Western
blotting (data not shown).
To facilitate the purification of the intact complex, we
developed a highly standardized protocol by rapid isolation of
recombinant pol d heterotetramer through immunoaffinity
chromatography and FPLC chromatography on Mono Q column
within 48 hours and storage at high protein concentration in
liquid nitrogen. This procedure allowed the purification of the pol
d four-subunit complex in an intact form to near-homogeneity and
kept the activity stable for at least 2 years. The purification was
monitored by both pol d activity assays and Western blotting
analysis. When the diluted supernatant faction after centrifugation
of collected hemolymph was loaded on the immunoaffinity
column, the pol d activities were eluted between the fraction 6
and 18. The activities around peak were stimulated by PCNA near
20-fold (Figure 4A). The fractions across peak contained all four
subunits of the expected molecular masses as judged by Western
blotting analysis (Figure 4B). In this step, we applied a ‘‘column
overloading’’ on immunoaffinity chromatography, assuring a
minimal non-specific protein binding. Therefore, there was still
a small amount of p125 in the flow-through fraction (Figure 4B).
In another protocol, when the supernatant from the lysate of pellet
fraction of hemolymph went through immunoaffinity column, the
activities were eluted between faction 9 and 18 and the peak
activity was stimulated by PCNA about 10-fold (Figure 4C).
Similar to the behavior of supernatant faction of hemolymph on
the column, the fractions across peak also contained all four
subunits of the expected molecular masses (Figure 4D). In later
case, we loaded a low protein concentration of the sample onto the
column which is below the binding capacity of immunoaffinity
beads. There was no any extra p125 in the flow-through fraction
where all p125 assemblies are bound onto the beads (Figure 4D).
However, in both cases, a comparable amount of other three
subunits in the flow-through fraction indicates a possibility of that
a subassembling occurred besides the four-subunit complex during
the expression of pol d in infected silkworm larvae.
The eluted fractions between 6 and 21 from immunoaffinity
column applied with supernatant faction of hemolymph (Figure 4A
and Figure 4B) were combined, dialyzed, and loaded on a Mono
Q 5/50 GL column. The peak activities of pol d were eluted
Figure 3. Western blotting analysis for the generation of the
recombinant BmNPV viruses in BmN cells. Eight bacmid DNAs,
isolated from the white clones and verified by PCR analysis, were
transfected into BmN cells. After 5 days post-transfection, each
supernatant was harvested as the viral stocks and the cell pellets were
analyzed by Western blotting using the antibodies specific for the
individual subunit as described under ‘‘Materials and Methods’’. M
indicates the positions in kDa of protein markers. The lanes from 1 to 8
show eight independent transfections of BmN cells with recombinant
BmNPV bacmid DNAs. Pol d four subunits are marked by arrows.
doi:10.1371/journal.pone.0022224.g003
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shown). Eluted fractions were judged by 12.5% SDS-PAGE and
stained with Coomassie Blue (Figure 5B) or Western blotting
analysis (Figure 5A). Thus, a protein complex containing four
subunits was obtained as expected molecular masses. From 350
larvae, we yielded about 4 mg of four-subunit protein complex
from the pooled Mono Q peak fractions 14–17 purified to near
homogeneity by our highly standardized protocol. A summary for
the specific activities and yield of preparations for purification of
recombinant pol d holoenzyme was shown in table 1.
Isolation of multi-subunit pol d from mammalian tissues has been
extremely difficulties. One of them is the case of the p68 subunit
which is prone to proteolytic nicking [9,11]. Rigorous isolation of
natural mammalian pol d resulted in no detectable p66 subunit in
protein preparations [17,18,34]. Even in the protocol which
demonstrated co-purification of p66 with p125 and p50, the p66
subunit was subject to proteolytic degradation and stoichiometri-
cally under-represented in the purified preparation [11]. In this
study, the four-subunit human pol d complex was reconstituted by
overexpression in silkworm larvae with the recombinant BmNPV
containingfoursubunitgeneexpressioncassettes.Rigorousisolation
of pol d activity from infected larvae led to the isolation of a near
homogeneous pol d heterotetramer in an intact form. No
degradation of the p68 subunit was observed in our preparation
(Figure 5).
Recent studies discovered a novel cellular response to DNA
damage. Exposure of mammalian cells to UV light or alkylating
agents led to the rapid degradation of the p12 subunit. Pol d was
consequently converted from a heterotetramer in vivo to a trimer
lacking the p12 subunit [27]. The loss of the p12 did not result in
the dissociation of the remaining subunits. This converted trimer
in vivo could be isolated as an intact complex of p125, p50, and
p68 using immunoaffinity chromatography with altered proper-
ties and behaviors when it encountered DNA base lesions
[27,28]. Previous studies also indicated that highly purified pol d
enzymes by immunoaffinity chromatography were polydisperse
on gel filtration. Further examination of the size of pol d by native
gel electrophoresis gave results which indicated the existence of
Figure 4. Purification of recombinant human pol d heterotetramer by immunoaffinity chromatography. Infected larval hemolymph was
centrifuged and divided into supernatant and pellet fractions. The supernatant fraction was subjected to immunoaffinity column. The lysates (BC),
flow-through (FT), wash (W), and eluted fractions were assayed for DNA polymerase activity in the presence (square) and absence (diamond) of PCNA
(panel A), and analyzed by 12.5% SDS-PAGE followed by Western blotting (panel B) using the antibodies specific for the individual subunit as
described under ‘‘Materials and Methods’’. A parallel purification for the pellet fraction was also performed. The activities were assayed (panel C) and
Western blotting analysis was carried out (panel D).
doi:10.1371/journal.pone.0022224.g004
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whether there exist subassemblies in vivo due to its intrinsic
property of pol d. In this work, when the sample was applied with
the pellet fraction of hemolymph containing cell debris and
tissues, the pol d subassemblies were separated and appeared in
Mono Q fractions (Figure S2). There are predominant pheno-
types of catalytic subunit p125 alone in fraction 12, dimer pol d-
core (p125/p50) in fraction 15, trimer pol d-p12 lacking p12 in
fraction 16, and four-subunit pol d complex in fraction 17,
respectively. This result implies the hypothesis that pol d might be
a mixture of subassemblies in vivo and contributes to the cellular
response to different events as a component, one of pol d
subassemblies, of the multi-protein replication and DNA repair
complexes.
Characterization of isolated recombinant four-subunit
human DNA pol d from supernatant fraction of
hemolymph of infected silkworm larvae
The specific activity of the recombinant pol d isolated by Mono
Q chromatography from the supernatant fraction of hemolymph
(Figure 6A1) was compared with that of native pol d isolated from
Hela cells by immunoaffinity chromatography (Figure 6A2) on
sparsely primed poly(dA)/oligo(dT) template-primer in the
presence and absence of PCNA. By the definition of one unit as
an incorporation of 1 nmole of dTMP per hour, the specific
activity of isolated recombinant pol d enzyme was calculated to be
25,000 units/mg, almost the same as the 25,600 units/mg of
purified native form pol d from Hela cells in this work (Figure 6B).
This value is also comparable to the 9,000 units/mg and 26,400
units/mg of characterized pol d preparations isolated from calf
thymus [11,18]. The stimulation level of isolated recombinant pol
d by PCNA was about 20 times, with the same stimulation level as
our preparation from Hela cells and comparable to the one (16-
fold) isolated from calf thymus [18].
To test more directly DNA elongation activity of our isolated
recombinant pold from MonoQ step, we analyzed itsactivity inthe
holoenzyme assay in which pol d activity is dependent on the
presence of RFC for the loading of PCNA. As expected, it efficiently
elongated primer DNA on single strand M13 DNA template. The
products generated in holoenzyme assay were analyzed by
electrophoresis on 1.5% alkaline-agarose gel followed by autoradi-
ography. By a 30-min incubation in the presence of auxiliary
factors, 100 fmoles of recombinant pol d efficiently replicated singly
primed M13 DNA mostly to completion, near 7 kb (Figure 6C). Its
behavior is similar to the native form pol d from Hela cell
preparation (Figure 6D). Thus, our preparation of recombinant pol
d isolated from the supernatant fraction of infected larvae
hemolymph is functionally indistinguishable from the native
enzyme prepared from either our preparation from Hela cells or
calf thymus by immunoaffinity chromatograph [11,18].
Figure 5. Purification of recombinant pol d heterotetramer by Mono Q chromatography from supernatant fraction of hemolymph.
The peak fractions (fractions 6–21) from the immunoaffinity chromatography step in which the column was applied with supernatant fraction of
hemolymph were combined and passed through a Mono Q column. The lysates (BC), flow-through (FT), and eluted fractions were analyzed by 12.5%
SDS-PAGE followed by Western blotting (panel A) or Coomassie Blue staining (panel B).
doi:10.1371/journal.pone.0022224.g005
Table 1. Purification of recombinant DNA polymerase d from infected silkworm larvae
a.
Step Total volume (ml) Protein (mg) Activity (Units) Specific activity (Units/mg)
Supernatant of hemolymph 50 297.5 ND
b —
Immunoaffinity 112.5 10.33 115696 11200
Mono Q 2.0 4.01 100250 25000
aThe purification procedure was carried out as described under Materials and Methods. DNA polymerase activity was followed by the assays on poly(dA)/oligo(dT)
template-primer.
bActivity in supernatant of hemolymph cannot be accurately measured.
doi:10.1371/journal.pone.0022224.t001
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between the yeast and mammalian system. Previous studies
reported a dimeric structure-like molecular weight of yeast pol d
complexes both in S. cerevisiae and in S. pombe [13,15,16]. However, a
more careful reinvestigation indicated that the yeast pol d complex
was not dimeric and the initial findings were attributed to the result
of an anomalous migration of the pold complex on gel filtration due
to an asymmetric structure [39]. In the case of mammalian pol d,a
280,000 of molecular weight of a heterotetrameric pol d complex,
reconstituted in infected Sf-9 cells, was reported by comparison to
protein standards on Superose 6 gel filtration [20]. A more accurate
molecular weight of 230,000 was determined by a calculation from
the Stokes radii and the sedimentation coefficients. To examine the
physical properties of recombinant human pol d complex isolated
from infected silkworm larvae hemolymph, itsmolecular weight was
estimated by comparison to protein standards on Superdex 200 gel
filtration using a logarithm plot of its molecular weight versus
elution volume. A 250 ml of sample from Mono Q peek fraction 15
Figure 6. Characterization of recombinant pol d heterotetramer complex. Panel A: Coomassie Blue protein stain of the pol d enzymes used
in this experiment. Lane 1 shows the recombinant pol d enzyme isolated from supernatant fraction of infected silkworm larvae hemolymph after
Mono Q chromatography step. Lane 2 shows the native pol d enzyme isolated from cultured Hela cells by immunoaffinity chromatography. Panel B: A
direct side-by-side comparison of recombinant pol d enzyme with the most highly purified native pol d enzyme from Hela cells on its specific
activities and response to PCNA (&, native pol d with PCNA; m, recombinant pol d with PCNA; e, native pol d without PCNA;6, recombinant pol d
without PCNA). Panel C: Analysis of DNA products synthesized by recombinant pol d holoenzyme on primed M13 DNA as described under ‘‘Materials
and Methods’’. Horizontal bars (Lane M) on the left indicate the positions in kb of DNA markers. Lane 1–2 show 200 fmoles of native pol d isolated
from Hela cells as the positive controls in the presence (Lane 1) and absence (Lane 2) of PCNA. The Lanes from Lane 3 to 7 show increasing amounts
of recombinant pol d enzyme (fmole) containing 0, 50, 100, 150, and 200, respectively. Panel D: Equal amounts of native form pol d enzyme from Hela
cell preparation analyzed in holoenzyme assay. The lanes from left to right show the increasing amounts of native enzyme of 50, 100, 150,
200 fmoles.
doi:10.1371/journal.pone.0022224.g006
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PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22224(Figure 5B) was passed through a Superdex 200 column. Western
blotting analysis of the collected fractions showed that all four
subunits were co-eluted around peak fraction 34 and there was no
apparent loss of subunits during this step, indicating that it did not
behave anomalously (Figure 7A). The estimated molecular weight
was about 280,000 based on a calibration curve as shown in
Figure 7B, which is consistent with those previously reported for the
native pol d complex and the reconstituted form from the infected
Sf-9 cells [9,20].
Pol d plays a significant role in base excision repair
Base excision repair (BER) is thought to be a major mechanism
in protecting cells from mutagenic base damage spontaneously
generated through normal cellular metabolism and also are caused
by exogenous agents, such as oxidative stress, hydrolysis, and
environmental factors. A typical process of BER is initiated by a
group of DNA-N-glycosylases and AP endonucleases and mediated
by at least two subpathways: single-nucleotide (SN) BER (filling
with one nucleotide) and long patch (LP) BER (filling with several
nucleotides leading to displacement of the parental strand). Pol b
has long been considered to be involved in base excision repair,
but other polymerases are likely to play an important role in this
pathway as well [33,40], because a defect in pol b has little impact
on cell proliferation [30]. Pol d, besides its crucial role in DNA
replication, also plays a significant role in DNA repair, and is
generally regarded as the primary enzyme that performs re-
synthesis (gap-filling) in various DNA repair processes [3,6,7]. Our
previous experiments showed a different behavior between pol d
heterotetramer and trimer lacking p12 to perform translesion
synthesis on templates containing base lesions (O
6-MeG, 8-oxoG,
an abasic site or a thyminethymine dimer) [28]. In order to reveal
the role of pol d involved in BER, we examined cell extract and
purified protein mediated uracil-intiated BER in vitro with uracil-
containing plasmid DNA. As shown in Figure 8B, left panel, the
pol b 2/2 cell extract (lane 3, 4) did not show a strong BER
deficiency under the conditions in this assay, compared with
extract from the wild-type MEF cell line (lane 1, 2). Pol b 2/2 cell
extract still retained significant repair activity, suggesting the
presence of a pol b-independent BER back-up pathway. We
depleted pol d four-subunit complex from wild type MEF and pol
b 2/2 cell extract by using the antibodies against its individual
four subunits (Figure 8B, right panel). As expected, the level of
BER significantly decreased, but a substantial level of BER still
persisted in pol d–depleted pol b 2/2 cell extract (lane 7, 8),
which implies that pol d plays a significant role in BER. On the
other hand, there may also exist other possible pol b-independent
BER pathways, for example, pol l or pol q.
To understand how pol d plays a role in BER, we monitored the
ratio of two BER subpathways in reconstitution BER assay with
purified recombinant proteins by measuring the SN BER and LP
BER repair patch size using uracil-containing plasmid pUC19N as
described in Materials and Methods. In such case, the kpnI-XhoI
digested repair products resulted in a
32P labeled 25-bp fragment in
which the uracil was replaced by [
32P]dCMP at the first C,
representing SN BER plus LP BER, whereas incorporation of
[
32P]dCMP at the second C and beyond resulted in a
32P labeled
16-bp fragment, representing LP BER (Figure 8A). The amount of
the SN BER product was calculated by subtracting the radioactivity
of the 16-bp fragment from that of the 25-bp fragment. As shown in
Figure 8C and 8D, pol d4 is more likely to mediate LP BER (58%),
compared with 42% of SN BER, while pol d3-p12 is more likely to
mediate SN BER (66%), compared with 34% of LP BER. Thus, it
seems likely that loss of p12 modulates the rate of SN BER and LP
BER during the repair process. These findings provide novel
insights into the role of p12 in human pol d function and into the
potential cellular consequences of the in vivo conversion of pol d4t o
pol d3-p12 [27]. It should be noted that in our experimental
condition, there are a lot of intermediate products between 41-bp
and 25-bp, also below 25-bp, especially in cell extract-mediated
BER reaction (Figure 8B), which is probably due to some nicks in
the plasmid DNA. Also, we did not see much difference in LP and
SN BER products between wild-type MEF and pol b 2/2 cell
extract. This could be due to the incubating reactions too long and
the substrate concentrations are below their Km. Much further
optimization is needed for our in vitro BER assay to avoid these
confounding factors.
Figure 7. Molecular weight determination of recombinant pol d heterotetramer complex. A 250 ml of sample from Mono Q peek fraction
15 was passed through a Superdex 200 column precalibrated with molecular weight standards. Panel A: The fractions across the peak of polymerase
activity were run on 12.5% SDS-PAGE and Western-blotted with the indicated antibodies. The pol d four subunits are marked by arrows. Panel B: The
diagram shows the calibration of the column that was used to estimate the molecular weight. The standards used here were: a, thyroglobulin
(667,000); b, ferritin (445,000); c, catalase (232,000); d, aldolase (158,000); e, bovine serum albumin (67,000). The elution position of the recombinant
heterotetramer complex is indicated by a vertical arrow. A calibration curve was plotted by the logarithm of molecular weights versus calculated Kav.
doi:10.1371/journal.pone.0022224.g007
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PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22224Figure 8. Contribution of pol d to SN and LP BER of uracil-containing plasmid DNA. Panel A: A schematic representation of the uracil-
containing plasmid DNA with KpnI and XhoI restriction-enzyme sites (underlined). After BER reaction, the repaired products were restricted with
indicated enzymes, and digested DNA fragments were separated on 16% denaturing polyacrylamide gel containing 8 M urea. DNA fragment sizes
and descriptions of DNA synthesis products are indicated. Panel B and C: Autoradiograph of gel electrophoresis to measure in vitro BER products. The
BER reaction was performed with cellular extracts (B), from wild-type MEF (lane 1, 2), pol b 2/2 (lane 3, 4) cells, pol d–depleted wild-type MEF (lane 5,
6), and pol d–depleted pol b 2/2 (lane 7, 8). The BER reaction was performed with purified enzymes (C), pol d4 (lane 1, 2) and pol d3-p12 (lane 3, 4).
Lane M indicates a
32P labeled 25-bp oligonucleotide as a DNA maker. Panel D: The ratio of SN BER and LP BER with purified pol d4 (upper panel) and
pol d3-p12 (lower panel). The amount of the SN BER product was calculated by subtracting the radioactivity of the 16-bp fragment from that of the
25-bp fragment.
doi:10.1371/journal.pone.0022224.g008
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PLoS ONE | www.plosone.org 11 July 2011 | Volume 6 | Issue 7 | e22224In summary, our work presents a major advance in the
expression and assembling of human DNA pol d in infected
silkworm larvae with a recombinant BmNPV virus in which the
cDNAs for pol d four subunits were constructed into a single virus,
each in an individual expression cassette. Highly purified
recombinant pol d, as much as 4 mg heterotetramer from 350
larvae by a standardized protocol, is shown to be functional similar
to those from natural sources by rigorous characterization and
comparison of its activities and homogeneity. Also pol d plays a
significant role by modulating the rate of SN BER and LP BER
during the repair process through its conversion from hetero-
tetrameric to trimeric form lacking p12. Pol d is a key enzyme in
DNA replication and repair, and defects in pol d have been linked
to genomic instability. Our research provides a simple novel
method for the large scale preparation of human DNA pol d,
which makes it feasible to study at the biochemical level various
cellular processes which may lead to or prevent the development
of cancer in human.
Supporting Information
Figure S1 Western blotting analysis for the generation
of recombinant viruses for pol d subassemblies. A set of
recombinant viruses for pol d subassemblies were prepared by the
transfection of BmN cells with the corresponding recombinant
BmNPV bacmid DNAs. The infected cell pellets were run on
12.5% SDS-PAGE and Western-blotted with the indicated
antibodies. M: the positions in kDa of protein markers. Lane
1–2: catalytic subunit p125 alone. Lane 3–4: dimer enzyme pol
d-core. Lane 5–6: trimer pol d-p12 lacking p12. Lane 7–8: trimer
pol d-p68 lacking p68. Lane 9–10: heterotetramer complex. Pol d
four subunits are marked by arrows.
(TIF)
Figure S2 Purification of recombinant pol d heterote-
tramer by Mono Q chromatography from pellet fraction
of hemolymph. The peak fractions from the immunoaffinity
chromatography step in which the column was applied with pellet
fraction of infected larvae hemolymph were combined and passed
through a Mono Q column. The lysates (BC) and the eluted
fractions were analyzed by 12.5% SDS-PAGE followed by
Coomassie Blue staining. Pol d four subunits are marked by
arrows.
(TIF)
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